中文 | English
Return
Total: 1044 , 1/105
Show Home Prev Next End page: GO
Author:(Yi-Cheng ZHANG)

2.Recombinant Interferon ?2a Synergistically Enhances SKOV3 Ovarian Tumor Cell Killing by the HSV-tk/GCV System

Yuejuan CHENG ; Lingya PAN ; Yi ZHANG

Chinese Journal of Cancer Biotherapy 1994;0(01):-

3.A New Species of the Genus Nanhaipotamon (Decapoda: Potamidae) from Xiapu County, Fujian

Youzhu CHENG ; Lisa LI ; Yi ZHANG

Chinese Journal of Parasitology and Parasitic Diseases 1987;0(04):-

4.Clinical application of double stapling technique in anus-preserving operation of low and middle rectal cancer

Faming ZHANG ; Qingliang ZENG ; Yi PAN ; Xiaoming CHENG ; Jiaping CHENG

Chinese Journal of Current Advances in General Surgery 1998;0(01):-

5.Survey of CT radiation dose to 1200 cancer patients

Shuli LI ; Qing LI ; Yi ZHANG ; Cheng LIU ; Lin ZHANG

Journal of International Oncology 2014;41(4):302-305

6.Study on the expression of TLR2 and TLR4 in peripheral blood mononuclear cells and their relation- ship with Th1/Th2 immune response in patients with Henoch-Schonlein purpura

Hong CHANG ; Qiuye ZHANG ; Na CHENG ; Shouqing ZHANG ; Yi LIN

Chinese Journal of Microbiology and Immunology 2013;(11):839-844

7.Application Research on Method of“Role of Identification”in Clinical Teaching

Yi ZHANG ; Min ZHANG ; Chenping LIU ; Na LAN ; Yanan CHENG

Chinese Journal of Information on Traditional Chinese Medicine 2015;(4):116-117,118

8.Enzyme-catalyzed synthesis of ASGPR ligand-targeted modifier in non-aqueous medium.

Yi CHENG ; Wei WU ; Dongqing ZHANG ; Yanzhen MAI

Acta Pharmaceutica Sinica 2010;45(9):1134-8

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1044 , 1/105 Show Home Prev Next End page: GO